How did your collaboration started
Our collaboration began somewhat unexpectedly. The initial introduction came through an international deeptech or biotech team, who were actively seeking truly radical and groundbreaking concepts in the life science space. They convinced me that the AQ Biotech team is exceptionally talented and that they have something radical in their laboratory but also recognising limitations to combine AI with multiomics and large metadata sources.
A Shared Vision for Integrated Health
What was inspiring to me was the immediate understanding and alignment of perspectives we shared and it became clear how similar our fundamental thoughts were regarding human health—not just as a collection of isolated systems, but recognizing the human body as a complex, integrated entity. This holistic view formed the bedrock of our partnership.
Ongoing projects and future outlook
As my role is to advise usage of AI which can integrate not only multiomics and metadata but also protein and peptide structures between phage biosensor and disease indicators. This work is independent of the disease in question but rather connected to the capabilities of the phage biosensors, and therefore we have a portfolio of impactful projects: prostate cancer, metastatic cancers, lung cancer, tuberculosis and neurodegenerative diseases, namely Parkinson’s disease.
Personally I am fascinated by the phage biosensor method and the information it can deliver combining high accuracy and cost-efficiency. It is exactly what early stage disease detection requires.
Active cooperation to deliver better results quicker
While writing this, we are in the process of analyzing anonymous clinical data and our biosensor data with external parties both from Finland and China. We have exclusive access to thousands of samples as well as to a world class AI in Life Sciences team at the Jiao Tong University in Shanghai. This new way of working promotes the complementary strengths of two countries and helps us all to move on quicker with better quality. Something we should do more to benefit from mutual strengths.
All in all, I am excited to see what we all as one team can make happen in years to come!
